(Q46288612)

21 December 2017

title

The oligometastatic state - separating truth from wishful thinking (English)

1 reference

21 December 2017

author

Suresh Senan

4

1 reference

21 December 2017

Ralph Weichselbaum

7

object named as

Ralph Weichselbaum

1 reference

21 December 2017

author name string

David A Palma

1

1 reference

21 December 2017

Joseph K Salama

2

1 reference

21 December 2017

Simon S Lo

3

1 reference

21 December 2017

Tom Treasure

5

1 reference

21 December 2017

Ramaswamy Govindan

6

1 reference

21 December 2017

language of work or name

English

0 references

publication date

24 June 2014

1 reference

21 December 2017

Nature Reviews Clinical Oncology

published in

1 reference

21 December 2017

volume

11

1 reference

21 December 2017

issue

9

1 reference

21 December 2017

page(s)

549-557

1 reference

21 December 2017

The surgical treatment of pulmonary metastases

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.96

Surgical management and outcomes of colorectal cancer liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.96

A survey of stereotactic body radiotherapy use in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.96

Chemotherapy in addition to supportive care improves survival in advanced non-small-cell lung cancer: a systematic review and meta-analysis of individual patient data from 16 randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.96

Systematic review and meta-analysis of randomised, phase II/III trials adding bevacizumab to platinum-based chemotherapy as first-line treatment in patients with advanced non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.96

Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.96

Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.96

Phase III trial of cisplatin plus gemcitabine with either placebo or bevacizumab as first-line therapy for nonsquamous non-small-cell lung cancer: AVAil

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.96

Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.96

Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.96

A critique of the role of the blood-brain barrier in the chemotherapy of human brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.96

A randomized trial of surgery in the treatment of single metastases to the brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.96

Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.96

Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.96

The history of adoption of hepatic resection for metastatic colorectal cancer: 1984-95.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.96

Is there an oligometastatic state in non-small cell lung cancer? A systematic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.96

Forty years on: pulmonary metastasectomy for sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.96

When professional opinion is not enough

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.96

Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.96

The natural history of hepatic metastases from colorectal cancer. A comparison with resective treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.96

Outcomes of adrenalectomy for isolated synchronous versus metachronous adrenal metastases in non-small-cell lung cancer: a systematic review and pooled analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.96

Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.96

Pulmonary oligometastases: metastasectomy or stereotactic ablative radiotherapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.96

Phase I study of individualized stereotactic body radiotherapy of liver metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.96

Stereotactic body radiation therapy for management of spinal metastases in patients without spinal cord compression: a phase 1-2 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.96

Stereotactic body radiotherapy for multisite extracranial oligometastases: final report of a dose escalation trial in patients with 1 to 5 sites of metastatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.96

Oligometastases treated with stereotactic body radiotherapy: long-term follow-up of prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.96

Feasibility and toxicity of hypofractionated image guided radiation therapy for large volume limited metastatic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.96

Oligometastatic breast cancer treated with curative-intent stereotactic body radiation therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.96

Hypofractionated image-guided radiation therapy for patients with limited volume metastatic non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.96

Phase II study on stereotactic body radiotherapy of colorectal metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.96

Stereotactic body radiotherapy for pulmonary metastases from soft-tissue sarcomas: excellent local lesion control and improved patient survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.96

Stereotactic body radiotherapy for the treatment of oligometastatic renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.96

Stereotactic body radiation therapy for melanoma and renal cell carcinoma: impact of single fraction equivalent dose on local control

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.96

Quality of life during chemotherapy in lung cancer patients: results across different treatment lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.96

Intermittent versus continuous oxaliplatin and fluoropyrimidine combination chemotherapy for first-line treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.96

Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.96

Immunologic correlates of the abscopal effect in a patient with melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.96

The controversial abscopal effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.96

How does ionizing irradiation contribute to the induction of anti-tumor immunity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.96

Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.96

Fractionated but not single-dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.96

The mechanism of anti-CTLA-4 activity and the negative regulation of T-cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.96

Hematopoetic stem cell transplantation for solid tumors in Europe.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.96

Abandonment of high-dose chemotherapy/hematopoietic cell transplants for breast cancer following negative trial results

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.96

High-dose chemotherapy with autologous hematopoietic stem-cell transplantation in metastatic breast cancer: overview of six randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.96

Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC 40004).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.96

Interpreting data from surgical follow-up studies: the role of modeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.96

Lung resection for colorectal metastases. 10-year results

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.96

Pulmonary resection for metastatic colorectal cancer: experiences with 159 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.96

Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.96

Immortal time bias in observational studies of drug effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.96

Durable complete responses in metastatic colorectal cancer treated with chemotherapy alone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.96

Surgical resection of pulmonary metastases from colorectal cancer: a systematic review of published series.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.96

Comparison of the effectiveness of radiotherapy with photons, protons and carbon-ions for non-small cell lung cancer: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.96

Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.96

Early Palliative Care for Patients with Metastatic Non–Small-Cell Lung Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.96

Pulmonary metastasectomy: a survey of current practice amongst members of the European Society of Thoracic Surgeons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.96

Pulmonary metastasectomy in colorectal cancer: a prospective study of demography and clinical characteristics of 543 patients in the Spanish colorectal metastasectomy registry (GECMP-CCR).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.96

Survival among patients with 10 or more brain metastases treated with stereotactic radiosurgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.96

Adjuvant chemotherapy after potentially curative resection of metastases from colorectal cancer: a pooled analysis of two randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.96

Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.96

Factors influencing survival after complete resection of pulmonary metastases from colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.96

MicroRNA expression characterizes oligometastasis(es)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.96

Oligo- and polymetastatic progression in lung metastasis(es) patients is associated with specific microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.96

Stereotactic ablative radiotherapy for comprehensive treatment of oligometastatic tumors (SABR-COMET): study protocol for a randomized phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.96

Gene signatures of pulmonary metastases of renal cell carcinoma reflect the disease-free interval and the number of metastases per patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.96

Radiographic changes after lung stereotactic ablative radiotherapy (SABR)--can we distinguish recurrence from fibrosis? A systematic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.96

Possible misinterpretation of demarcated solid patterns of radiation fibrosis on CT scans as tumor recurrence in patients receiving hypofractionated stereotactic radiotherapy for lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.96

Phase 1 study of concurrent sunitinib and image-guided radiotherapy followed by maintenance sunitinib for patients with oligometastases: acute toxicity and preliminary response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.96

Local ablative therapy of oligoprogressive disease prolongs disease control by tyrosine kinase inhibitors in oncogene-addicted non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.96

Pulmonary metastasectomy in colorectal cancer: the PulMiCC trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.96

Oligometastases and oligo-recurrence: the new era of cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.96

Outcomes after Resection of Synchronous or Metachronous Hepatic and Pulmonary Colorectal Metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.96

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.96

Karnofsky Memorial Lecture. Natural history of small breast cancers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.96

Single agent versus combination chemotherapy for metastatic breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.96

Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Française de Chirurgie

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.96

Liver metastases from breast cancer: long-term survival after curative resection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.96

Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.96

Analysis of patients with oligometastases undergoing two or more curative-intent stereotactic radiotherapy courses

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.96

Cumulative toxicities from cisplatin therapy and current cytoprotective measures

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.96

Abscopal effect in a patient with melanoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.96

High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.96

Cisplatin and gemcitabine treatment for malignant mesothelioma: a phase II study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.96

Researchers struggle with trials of stem-cell transplants for breast cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.96

The controversy over high-dose chemotherapy with autologous bone marrow transplant for breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.96

How American oncologists treat breast cancer: an assessment of the influence of clinical trials

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.96

The effect of metastasectomy: fact or fiction?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.96

Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.96

Non-small cell lung cancer: a study of long-term survival after vinorelbine monotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.96

Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.96

Of mice but not men. Problems of the randomized clinical trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.96

Patterns of recurrence after curative-intent radiation for oligometastases confined to one organ

31 March 2020

1 reference

12 December 2020

The Norton-Simon hypothesis revisited

1 reference

12 December 2020

The surgical management of metastatic neoplasms in the lung

1 reference

12 December 2020

Cost-effectiveness of hepatic metastasectomy in patients with metastatic colorectal carcinoma: a state-transition Monte Carlo decision analysis

1 reference

12 December 2020

High-dose chemotherapy for primary breast cancer: facts versus anecdotes.

1 reference

12 December 2020

Chaos surrounds high-dose chemotherapy for breast cancer

1 reference

12 December 2020

10.1038/NRCLINONC.2014.96

Identifiers

DOI

1 reference

21 December 2017

1 reference

21 December 2017